Literature DB >> 15703864

Effect of atorvastatin on markers of bone turnover.

Alan J Martin, M Casey, M Healy, J B Walsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15703864     DOI: 10.1007/s00198-004-1824-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  5 in total

1.  Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis.

Authors:  P Garnero; O Borel; P D Delmas
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

2.  Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.

Authors:  Heiner K Berthold; Susanne Unverdorben; Armin Zittermann; Ralf Degenhardt; Bernhard Baumeister; Martin Unverdorben; Wilhelm Krone; Hans Vetter; Ioanna Gouni-Berthold
Journal:  Osteoporos Int       Date:  2004-02-14       Impact factor: 4.507

3.  Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.

Authors:  Yu Z Bagger; László B Tankó; Peter Alexandersen; Pernille Ravn; Claus Christiansen
Journal:  Bone       Date:  2003-09       Impact factor: 4.398

4.  Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.

Authors:  R Hannon; A Blumsohn; K Naylor; R Eastell
Journal:  J Bone Miner Res       Date:  1998-07       Impact factor: 6.741

5.  Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes.

Authors:  Hiroshi Hatano; Akihiro Maruo; Mark E Bolander; Gobinda Sarkar
Journal:  J Orthop Sci       Date:  2003       Impact factor: 1.601

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.